Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page
- Check7 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This signals a new site revision without changes to study content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a small release update applied to the page’s underlying platform.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe page revision line was updated from v3.6.2 to v3.6.3, indicating a small metadata update to the page without changes to the study information.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the documentation. This update appears administrative rather than affecting the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedEnrollment status updated to no longer recruit participants, and new sections including How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment area were added, along with a revision notice (Revision: v3.6.0).SummaryDifference0.4%

- Check71 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4; this appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.